Restricted accessResearch articleFirst published online 2024-10
Determining the Disinfectants Resistance Genes and the Susceptibility to Common Disinfectants of Extensively Drug-Resistant Carbapenem-Resistant Klebsiella pneumoniae Strains at a Tertiary Hospital in China
Carbapenem-resistant Klebsiella pneumoniae (CRKP) infection has become a significant threat to global health. The application of chemical disinfectants is an effective infection control strategy to prevent the spread of CRKP in hospital environments. However, bacteria have shown reduced sensitivity to clinical disinfectants in recent years. Furthermore, bacteria can acquire antibiotic resistance due to the induction of disinfectants, posing a considerable challenge to hospital infection prevention and control. This study collected 68 CRKP strains from the Fifth Affiliated Hospital of Xinjiang Medical University in China from 2023 to 2024. These strains were isolated from the sputum, urine, and whole blood samples of patients diagnosed with CRKP infection. Antibiotic susceptibility tests were performed on CRKP strains. Concurrently, the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of disinfectants (benzalkonium bromide, 1% iodophor disinfectant, alcohol, and chlorine-containing disinfectant) against the test isolates were determined by the broth microdilution method. The efflux pump genes (cepA, qacE, qacEΔ1, qacEΔ1-SUL1, oqxA, and oqxB) were detected using polymerase chain reaction. The results showed that 21 out of the 68 CRKP strains exhibited extensive drug resistance, whereas 47 were nonextensively drug-resistant. The MIC value for benzalkonium bromide disinfectants displayed statistically significant differences (p < 0.05) between extensively drug-resistant (XDR) and non-XDR strains. Additionally, the MBC values for benzalkonium bromide disinfectants and 1% iodophor disinfectants displayed statistically significant differences (p < 0.05) between XDR and non-XDR strains. The detection rates for the efflux pump genes were as follows: cepA 52.9%, qacE 39.7%, qacEΔ1 35.2%, qacEΔ1-SUL1 52.9%, oqxA 30.8%, and oqxB 32.3%. The detection rate of the qacEΔ1-SUL1 gene in XDR CRKP strains was significantly higher than in non-XDR CRKP strains (p < 0.05). This indicates a potential link between CRKP bacterial disinfectant efflux pump genes and CRKP bacterial resistance patterns. Ongoing monitoring of the declining sensitivity of XDR strains against disinfectants is essential for the effective control and prevention of superbug.
WyresKL, HoltKE. Klebsiella pneumoniae as a key trafficker of drug resistance genes from environmental to clinically important bacteria. Curr Opin Microbiol, 2018; 45:131–139.
4.
PitoutJD, NordmannP, PoirelL. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother, 2015; 59(10):5873–5884.
5.
JohnsonJK, RobinsonGL, PinelesLL, et al.Carbapenem MICs in Escherichia coli and Klebsiella species producing extended-spectrum β-lactamases in critical care patients from 2001 to 2009. Antimicrob. Agents Chemother2017; 61(4):1–13.
6.
LeshoE, ChukwumaU, SparksM, et al.Anatomic, geographic, and taxon-specific relative risks of carbapenem resistance in the health care system of the U.S. Department of Defense. J Clin Microbiol, 2016; 54(6):1546–1551.
7.
PaczosaMK, MecsasJ. Klebsiella pneumoniae: Going on the offense with a strong defense. Microbiol Mol Biol Rev, 2016; 80(3):629–661.
8.
XuL, SunX, MaX. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob, 2017; 16(1):18.
9.
IredellJ, BrownJ, TaggK. Antibiotic resistance in Enterobacteriaceae: Mechanisms and clinical implications. BMJ, 2016; 352:h6420.
10.
Fraenkel-WandelY, Raveh-BrawerD, Wiener-WellY, et al.Mortality due to BLKPC Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother, 2016; 71(4):1083–1087.
11.
Al-MustaphaAI, AladaSA, RaufuIA, et al.Co-occurrence of antibiotic and disinfectant resistance genes in extensively drug-resistant Escherichia coli isolated from broilers in Ilorin, North Central Nigeria. J Glob Antimicrob Resist, 2022; 31:337–344.
12.
MagiorakosAP, SrinivasanA, CareyRB, et al.Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect, 2012; 18(3):268–281.
13.
TängdénT, GiskeCG. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: Clinical perspectives on detection, treatment and infection control. J Intern Med, 2015; 277(5):501–512.
14.
ZhenX, Stålsby LundborgC, SunX, et al.Clinical and economic burden of carbapenem-resistant infection or colonization caused by Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii: A multicenter study in China. Antibiotics (Basel, Switz), 2020; 9(8):514–517.
15.
GeraldesC, TavaresL, GilS, et al.Biocides in the hospital environment: Application and tolerance development. Microb Drug Resist, 2023; 29(10):456–476.
16.
SehulsterL, ChinnRY, HICPAC. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep, 2003; 52(RR–10):1–42.
17.
LingML, ChingP, WiditaputraA, et al.APSIC guidelines for disinfection and sterilization of instruments in health care facilities. Antimicrob Resist Infect Control, 2018; 7:25–32.
18.
BetchenM, GiovincoHM, CurryM, et al.Evaluating the effectiveness of hospital antiseptics on multidrug-resistant Acinetobacter baumannii: Understanding the relationship between microbicide and antibiotic resistance. Antibiotics (Basel, Switz, 2022; 11(5):614–615.
19.
LepelletierD, MaillardJY, PozzettoB, et al.Povidone iodine: Properties, mechanisms of action, and role in infection control and Staphylococcus aureus decolonization. Antimicrob. Agents Chemother, 2020; 64(9).
20.
McDonnellG, RussellAD. Antiseptics and disinfectants: Activity, action, and resistance. Clin Microbiol Rev, 1999; 12(1):147–179.
21.
LuterbachCL, ChenL, KomarowL, et al.Multi-Drug Resistant Organism Network Investigators Network Investigators and the Antibacterial Resistance Leadership Group. Transmission of carbapenem-resistant Klebsiella pneumoniae in US hospitals. Clin Infect Dis, 2023; 76(2):229–237.
22.
WesgateR, GrashaP, MaillardJY. Use of a predictive protocol to measure the antimicrobial resistance risks associated with biocidal product usage. Am J Infect Control, 2016; 44(4):458–464.
23.
BhatiaM, LoombaPS, MishraB, et al.Reduced susceptibility of carbapenem-resistant Klebsiella pneumoniae to biocides: An emerging threat. Indian J Med Microbiol, 2016; 34(3):355–358.
24.
KimM, WeigandMR, OhS, et al.Widely used benzalkonium chloride disinfectants can promote antibiotic resistance. Appl Environ Microbiol, 2018; 84(17):35–42.
25.
Namaki KheljanM, TeymorpourR, Peeri DoghahehH, et al.Antimicrobial biocides susceptibility and tolerance-associated genes in Enterococcus faecalis and Enterococcus faecium isolates collected from human and environmental sources. Curr Microbiol, 2022; 79(6):170–177.
26.
PartridgeSR, KwongSM, FirthN, et al.Mobile genetic elements associated with antimicrobial resistance. Clin Microbiol Rev, 2018; 31(4):89–97.
27.
NiL, ZhangZ, ShenR, et al.Disinfection strategies for carbapenem-resistant Klebsiella pneumoniae in a healthcare facility. Antibiotics, 2022; 11(6):1–14.
28.
GuoW, ShanK, XuB, et al.Determining the resistance of carbapenem-resistant Klebsiella pneumoniae to common disinfectants and elucidating the underlying resistance mechanisms. Pathog Glob Health, 2015; 109(4):184–192.
29.
ChenY, LiaoK, HuangY, et al.Determining the susceptibility of carbapenem-resistant Klebsiella pneumoniae and Escherichia coli strains against common disinfectants at a tertiary hospital in China. BMC Infect. Dis., 2020; 20(1):88–96.
30.
ZhongX, XuH, ChenD, et al.First emergence of ACRAB and OQXAB mediated tigecycline resistance in clinical isolates of Klebsiella pneumoniae pre-dating the use of tigecycline in a Chinese hospital. PLoS One, 2014; 9(12):e115185.
31.
KückenD, FeuchtH, KaulfersP. Association of qace and qacedelta1 with multiple resistance to antibiotics and antiseptics in clinical isolates of gram-negative bacteria. FEMS Microbiol Lett, 2000; 183(1):95–98.
32.
NaparstekL, CarmeliY, ChmelnitskyI, et al.Reduced susceptibility to chlorhexidine among extremely-drug-resistant strains of Klebsiella pneumoniae. J Hosp Infect, 2012; 81(1):15–19.
33.
GadeaR, Fernández FuentesM, Pérez PulidoR, et al.Effects of exposure to quaternary-ammonium-based biocides on antimicrobial susceptibility and tolerance to physical stresses in bacteria from organic foods. Food Microbiol, 2017; 63:58–71.
34.
El-BannaT, Abd El-AzizA, SonbolF, et al.Adaptation of Pseudomonas aeruginosa clinical isolates to benzalkonium chloride retards its growth and enhances biofilm production. Mol Biol Rep, 2019; 46(3):3437–3443.
35.
Talebi-TaherM, MajidpourG, GholamiA, et al.Role of efflux pump inhibitor in decreasing antibiotic cross-resistance of Pseudomonas aeruginosa in a burn hospital in Iran. J Infect Dev Ctries, 2016; 10(6):600–604.
36.
HumphriesR, BobenchikAM, HindlerJA, et al.Overview of changes to the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing, M100, 31st edition. J Clin Microbiol, 2021; 59(12):e0021321.
AbuzaidAA, AmyesSG. The genetic environment of the antiseptic resistance genes qaceδ1 and cepa in Klebsiella pneumoniae. J Chemother, 2015; 27(3):139–144.
40.
GomaaF, A, M, HelalZH, KhanMI. High prevalence of bla(NDM-1), bla(VIM), qace, and qaceδ1 genes and their association with decreased susceptibility to antibiotics and common hospital biocides in clinical isolates of Acinetobacter baumannii. Microorganisms, 2017; 5(2):1–12.
41.
QinX, WuS, HaoM, et al.The colonization of carbapenem-resistant Klebsiella pneumoniae: Epidemiology, resistance mechanisms, and risk factors in patients admitted to intensive care units in China. J Infect Dis, 2020; 221(Suppl 2):S206–S214.
ChenSJ, ZhangWQ, LinYL, et al.High prevalence of carbapenem-resistant Enterobacterales colonization among intensive care unit patients in a tertiary hospital, China. Microb Drug Resist, 2023; 29(12):568–575.
44.
RojasLJ, SalimM, CoberE, et al.Antibacterial Resistance Leadership Group. Colistin resistance in carbapenem-resistant Klebsiella pneumoniae: Laboratory detection and impact on mortality. Clin Infect Dis, 2017; 64(6):711–718.
45.
MalingaNZZ, ShoboCO, MolechanC, et al.Molecular surveillance and dissemination of Klebsiella pneumoniae on frequently encountered surfaces in South African public hospitals. Microb Drug Resist, 2022; 28(3):306–316.
46.
LinXC, LiCL, ZhangSY, et al.The global and regional prevalence of hospital-acquired carbapenem-resistant Klebsiella pneumoniae infection: A systematic review and meta-analysis. Open Forum Infect. Dis, 2024; 11(2):ofad649.
47.
OliveiraR, CastroJ, SilvaS, et al.Exploring the antibiotic resistance profile of clinical Klebsiella pneumoniae isolates in Portugal. Antibiotics (Basel), 2022; 11(11):69–75.
48.
El-BadawyMF, El-FarSW, AlthobaitiSS, et al.The first Egyptian report showing the co-existence of bla(NDM-25), bla(OXA-23), bla(OXA-181), and bla(GES-1) among carbapenem-resistant K. pneumoniae clinical isolates genotyped by BOX-PCR. Infect. Drug Resist, 2020; 13:1237–1250.
49.
AnX, XieW, ZhengX, et al.Detection and analysis of carbapenem-resistant Klebsiella pneumoniae resistance genes in five hospitals in Qingdao City. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 2020; 32(2):145–149.
50.
ZhuJ, ChenY, YangX. Antibiotic resistance, molecular characteristics, and risk factors of carbapenem-resistant Klebsiella pneumoniae in clinical isolates. Infect Drug Resist, 2022; 15:6671–6680.
51.
FugaB, SelleraFP, CerdeiraL, et al.WHO critical priority Escherichia coli as one health challenge for a post-pandemic scenario: Genomic surveillance and analysis of current trends in Brazil. Microbiol Spectr, 2022; 10(2):e0125621.
52.
TzouvelekisLS, MarkogiannakisA, PsichogiouM, et al.Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: An evolving crisis of global dimensions. Clin Microbiol Rev, 2012; 25(4):682–707.
53.
AnariRK, NikkhahiF, JavadiA, et al.Evaluation of antibacterial activity of five biocides and the synergistic effect of biocide/EDTA combinations on biofilm-producing and non-producing Stenotrophomonas maltophilia strains isolated from clinical specimens in Iran. BMC Microbiol, 2022; 22(1):257–263.
54.
KhanH, LiuM, KayaniMUR, et al.DNA phosphorothioate modification facilitates the dissemination of mcr-1 and bla(NDM-1) in drinking water supply systems. Environ Pollut, 2021; 268(Pt A):115799.
55.
VijayakumarR, SandleT. A review on biocide reduced susceptibility due to plasmid-borne antiseptic-resistant genes-special notes on pharmaceutical environmental isolates. J Appl Microbiol, 2019; 126(4):1011–1022.
56.
SteinC, VinczeS, KippF, et al.Carbapenem-resistant Klebsiella pneumoniae with low chlorhexidine susceptibility. Lancet Infect Dis, 2019; 19(9):932–933.
57.
VijayakumarR, SandleT, Al-AboodyMS, et al.Distribution of biocide resistant genes and biocides susceptibility in multidrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii—A first report from the Kingdom of Saudi Arabia. J Infect Public Health, 2018; 11(6):812–816.
58.
HuZ, YangL, LiuZ, et al.Excessive disinfection aggravated the environmental prevalence of antimicrobial resistance during COVID-19 pandemic. Sci Total Environ, 2023; 882:163598.
59.
AmsaluA, SapulaSA, De Barros LopesM, et al.Efflux pump-driven antibiotic and biocide cross-resistance in Pseudomonas aeruginosa isolated from different ecological niches: A case study in the development of multidrug resistance in environmental hotspots. Microorganisms, 2020; 8(11):7–26.
60.
MonárrezR, BraunM, Coburn-FlynnO, et al.A large self-transmissible resistance plasmid from Nigeria contains genes that ameliorate a carrying cost. Sci Rep, 2019; 9(1):19624.
61.
AzadpourM, NowrooziJ, GoudarziGR, et al.Presence of qaceδ1 and cepa genes and susceptibility to a hospital biocide in clinical isolates of Klebsiella pneumoniae in Iran. Trop Biomed, 2015; 32(1):109–115.
62.
WuYH, WangYH, XueS, et al.Increased risks of Antibiotic Resistant Genes (ARGs) induced by chlorine disinfection in the reverse osmosis system for potable reuse of reclaimed water. Sci Total Environ, 2022; 815:152860.
63.
RoedelA, DieckmannR, BrendebachH, et al.Biocide-tolerant Listeria monocytogenes isolates from German food production plants do not show cross-resistance to clinically relevant antibiotics. Appl Environ Microbiol, 2019; 85(20):1–7.
64.
CottellA, DenyerSP, HanlonGW, et al.Triclosan-tolerant bacteria: Changes in susceptibility to antibiotics. J Hosp Infect, 2009; 72(1):71–76.
65.
LiuX, GongL, LiuE, et al.Characterization of the disinfectant resistance genes qaceδ1 and cepa in carbapenem-resistant Klebsiella pneumoniae isolates. Am J Trop Med Hyg, 2024; 110(1):136–141.
66.
JinZ, WangZ, GongL, et al.Molecular epidemiological characteristics of carbapenem-resistant Klebsiella pneumoniae among children in China. AMB Express, 2022; 12(1):89.
67.
GuoJ, LiC. Molecular epidemiology and decreased susceptibility to disinfectants in carbapenem-resistant Acinetobacter baumannii isolated from intensive care unit patients in Central China. J Infect Public Health, 2019; 12(6):890–896.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
